Dr. Obama is in the house
April 21, 2009 by Katie Quackenbush
More than $1 billion from the American Recovery and Reinvestment Act is earmarked for comparative effectiveness research. What will that mean for the Commonwealth's medical device sector?
Suzanne Ryan has a bum knee. If she doesn’t spend most of the day sitting down, she ends up coping with a lot of pain.
Her doctors say there are two options for the semi-retired elementary school teacher: Knee replacement surgery, using state-of-the-art plastic implants, or periodic injections to reduce inflammation and pain and improve joint flexibility.
When MassDevice first speaks with Ryan, in March, she's unsure which offers the best chance of regaining mobility.
"I’m not sure which treatment I’ll choose,” Ryan says. "The device or the drugs."
President Barack Obama wants to help her decide.
Similar entries
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
Features
